Perspectives on integrated continuous bioprocessing — opportunities and challenges

Biopharmaceuticals are currently produced almost entirely using batch operations. Integrated continuous processes have the potential to revolutionize bioprocessing, leading to significant reductions in manufacturing costs and facility size while improving product quality through enhanced uniformity in the microenvironment. This paper examines the potential opportunities and challenges in implementing continuous processes for the production of high value biological products. Although regulatory agencies seem highly open to continuous processing, there are significant technical and practical issues that must be addressed to move the industry in this direction, including the development of effective alternatives to traditional downstream processing operations. Continuous processing could provide unique opportunities for the production and delivery of low-cost biopharmaceuticals for solution of major global health challenges in the coming decades.

[1]  Konstantin B Konstantinov,et al.  White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium. , 2015, Journal of pharmaceutical sciences.

[2]  Marcella Yu,et al.  Effects of cell culture conditions on antibody N‐linked glycosylation—what affects high mannose 5 glycoform , 2011, Biotechnology and bioengineering.

[3]  Jemelle Dizon-Maspat,et al.  Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production , 2012, Biotechnology and bioengineering.

[4]  Mohamed Al-Rubeai,et al.  Bioreactor systems for the production of biopharmaceuticals from animal cells , 2006, Biotechnology and applied biochemistry.

[5]  Alois Jungbauer,et al.  Preparative continuous annular chromatography (P-CAC), a review , 2002, Bioprocess and biosystems engineering.

[6]  Konstantin B Konstantinov,et al.  The future of industrial bioprocessing: batch or continuous? , 2015, Biotechnology and bioengineering.

[7]  G. Carta,et al.  Unfolding and aggregation of a glycosylated monoclonal antibody on a cation exchange column. Part II. Protein structure effects by hydrogen deuterium exchange mass spectrometry. , 2014, Journal of chromatography. A.

[8]  Alois Jungbauer,et al.  Continuous downstream processing of biopharmaceuticals. , 2013, Trends in biotechnology.

[9]  R Fuchs,et al.  Practical Considerations in Operation and Scale‐up of Spin‐Filter Based Bioreactors for Monoclonal Antibody Production , 1996, Biotechnology progress.

[10]  A. Livingston,et al.  Continuous purification of active pharmaceutical ingredients using multistage organic solvent nanofiltration membrane cascade , 2014 .

[11]  Daniel Cummings,et al.  Integrated continuous production of recombinant therapeutic proteins , 2012, Biotechnology and bioengineering.

[12]  F Meuwly,et al.  Potential of cell retention techniques for large‐scale high‐density perfusion culture of suspended mammalian cells , 2003, Biotechnology and bioengineering.

[13]  Suzanne S Farid,et al.  Continuous bioprocessing: The real thing this time? , 2014, mAbs.

[14]  Massimo Morbidelli,et al.  A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process , 2007, Biotechnology and bioengineering.

[15]  Marco Rito-Palomares,et al.  Continuous aqueous two-phase systems devices for the recovery of biological products , 2014 .

[16]  M. Lay,et al.  Continuous Radial Flow Chromatography of Proteins , 2006 .

[17]  Andrew L. Zydney,et al.  Bioprocess membrane technology , 2007 .

[18]  M. Perc,et al.  Resolution of the Stochastic Strategy Spatial Prisoner's Dilemma by Means of Particle Swarm Optimization , 2011, PloS one.

[19]  Andrew L. Zydney,et al.  Continuous downstream processing for high value biological products: A Review , 2016, Biotechnology and bioengineering.

[20]  Bernd Kammerer,et al.  Towards Protein Crystallization as a Process Step in Downstream Processing of Therapeutic Antibodies: Screening and Optimization at Microbatch Scale , 2011, PloS one.

[21]  Nitin Yadav,et al.  Avoiding antibody aggregation during processing: Establishing hold times , 2014, Biotechnology journal.

[22]  Hongcheng Liu,et al.  Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[23]  J. Birch,et al.  Large-scale cell culture in biotechnology. , 1986, Science.

[24]  Melissa A. Holstein,et al.  Downstream bioprocessing: recent advances and future promise , 2011 .

[25]  Anurag S Rathore,et al.  Continuous Processing for Production of Biopharmaceuticals , 2015, Preparative biochemistry & biotechnology.

[26]  Allan S. Myerson,et al.  Continuous Plug Flow Crystallization of Pharmaceutical Compounds , 2010 .

[27]  Andrew D. Tustian,et al.  Purification of monoclonal antibodies from clarified cell culture fluid using Protein A capture continuous countercurrent tangential chromatography. , 2015, Journal of biotechnology.

[28]  Gintaras V. Reklaitis,et al.  Process systems engineering: From Solvay to modern bio- and nanotechnology.: A history of development, successes and prospects for the future , 2011 .

[29]  Matthias Wessling,et al.  In situ product recovery: Submerged membranes vs. external loop membranes , 2012 .

[30]  José P. S. Aniceto,et al.  Simulated Moving Bed Strategies and Designs: From Established Systems to the Latest Developments , 2015 .

[31]  J. O’Connell,et al.  Unfolding of a model protein on ion exchange and mixed mode chromatography surfaces. , 2014, Journal of chromatography. A.

[32]  S. Lute,et al.  Analysis of viral clearance unit operations for monoclonal antibodies , 2010, Biotechnology and bioengineering.

[33]  Alois Jungbauer,et al.  Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation. , 2014, Biotechnology journal.

[34]  Jason Walther,et al.  The business impact of an integrated continuous biomanufacturing platform for recombinant protein production. , 2015, Journal of biotechnology.

[35]  Frank Riske,et al.  Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins. , 2012, Biotechnology journal.

[36]  Jason Condon,et al.  Understanding and modeling alternating tangential flow filtration for perfusion cell culture , 2014, Biotechnology progress.

[37]  Suresh Vunnum,et al.  Cation exchange surface-mediated denaturation of an aglycosylated immunoglobulin (IgG1). , 2012, Journal of chromatography. A.